Suchergebnisse - (Person:"Wagner, Kathryn R")

PubPharm (197)

1

Safety and efficacy of losmapimod in facioscapulohumeral muscular dystrophy (ReDUX4) : a randomised, double-blind, placebo-controlled phase 2b trial

enthalten in: The Lancet. Neurology | 2024

von Tawil, R. | Wagner, K. | Hamel, J. | +36

2

Racial and ethnic diversity in global neuroscience clinical trials

enthalten in: Contemporary clinical trials communications | 2024

von Rutten-Jacobs, L. | McIver, T. | Reyes, A. | +5

3

The Clinical Development of Taldefgrobep Alfa : An Anti-Myostatin Adnectin for the Treatment of Duchenne Muscular Dystrophy

enthalten in: Neurology and therapy | 2024

von Muntoni, F. | Byrne, B. | McMillan, H. | +114

4

The Clinical Development of Taldefgrobep Alfa: An Anti-Myostatin Adnectin for the Treatment of Duchenne Muscular Dystrophy

enthalten in: Neurology and Therapy | 2024

von Muntoni, F. | Byrne, B. | McMillan, H. | +13

5

Correction to : Risdiplam in Patients Previously Treated with Other Therapies for Spinal Muscular Atrophy: An Interim Analysis from the JEWELFISH Study

enthalten in: Neurology and therapy | 2023

von Chiriboga, C. | Bruno, C. | Duong, T. | +114

ErratumFor: Neurol Ther. 2023 Apr;12(2):543-557. - PMID 36780114

6

Lean tissue mass measurements by dual-energy X-ray absorptiometry and associations with strength and functional outcome measures in facioscapulohumeral muscular dystrophy

enthalten in: Neuromuscular disorders : NMD | 2023

von Wang, L. | Leung, D. | Wagner, K. | +20

7

Correction to: Risdiplam in Patients Previously Treated with Other Therapies for Spinal Muscular Atrophy: An Interim Analysis from the JEWELFISH Study

enthalten in: Neurology and Therapy | 2023

von Chiriboga, C. | Bruno, C. | Duong, T. | +13

8

Correction to: Risdiplam in Patients Previously Treated with Other Therapies for Spinal Muscular Atrophy: An Interim Analysis from the JEWELFISH Study

enthalten in: Neurology and Therapy | 2023

von Chiriboga, C. | Bruno, C. | Duong, T. | +13

9

Microdystrophin Expression as a Surrogate Endpoint for Duchenne Muscular Dystrophy Clinical Trials

enthalten in: Human gene therapy | 2023

von Chamberlain, J. | Robb, M. | Braun, S. | +11

10

Risdiplam in Patients Previously Treated with Other Therapies for Spinal Muscular Atrophy : An Interim Analysis from the JEWELFISH Study

enthalten in: Neurology and therapy | 2023

von Chiriboga, C. | Bruno, C. | Duong, T. | +114

ErratumIn: Neurol Ther. 2023 Oct;12(5):1799-1801. - PMID 37395990

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[20]